FibroBiologics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -234 | -231 | ||
EBITDA | -4,033 | -4,759 | -2,806 | -5,547 |
EBIT | -4,996 | -3,040 | -5,778 | |
Net Income | -4,117 | -5,000 | -3,244 | -5,778 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,291 | -4,364 | -3,163 | -3,978 |
Cash | 3,515 | 1,482 | 4,894 | 4,867 |
Basic Shares | 3,772 | 3,772 | 3,325 | 2,153 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -832 | -573 | -437 | -94 |
EBITDA | -17,610 | -10,568 | -15,901 | -4,373 |
EBIT | -18,442 | -11,141 | -16,338 | -4,467 |
Net Income | -18,646 | -11,161 | -16,485 | -5,121 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,656 | -12,085 | -6,896 | -4,066 |
Cash | 4,894 | 13,985 | 9,163 | 2,266 |
Basic Shares | 2,233 | 1,643 | 1,624 | 1,623 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.66 |
2026-03-31 | -$1.33 |
2025-12-31 | -$0.60 |
2025-09-30 | -$2.60 |